Interleukin-6 levels are increased in temporal lobe epilepsy but not in extra-temporal lobe epilepsy

被引：0

作者：

Suvi Liimatainen

Mahdi Fallah

Elham Kharazmi

Maria Peltola

Jukka Peltola

机构：

[1] Tampere University Hospital,Department of Neurology and Rehabilitation

[2] University of Tampere,Tampere School of Public Health

来源：

Journal of Neurology | 2009年 / 256卷

关键词：

Refractory focal epilepsy; Cytokines; Epilepsy type;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Previous studies have reported activation of inflammatory cytokines in seizures, but clinical characteristics of epilepsy associated with cytokine activation have not been well established. In this study, serum levels of interleukin-6 (IL-6) and interleukin-1 receptor antagonist (IL-1RA) were measured, and clinical characteristics of epilepsy were assessed in 86 well-evaluated patients with refractory focal epilepsy and in 5 patients with controlled focal epilepsy. Epilepsy was evaluated based on patient histories, electroclinical findings, and high-resolution brain MRI scans. Sixty-three healthy blood donors served as controls. IL-6 concentrations were chronically increased in epilepsy patients (11%) compared with healthy controls (0%) (P = 0.007). Increased levels of IL-6 were more prevalent in patients with temporal lobe epilepsy (TLE) compared to patients with extra-TLE (P = 0.028). Also the mean and the median serum levels of IL-6 were higher in patients with TLE than in patients with extra-TLE (P = 0.042). Concentrations of IL-1RA were not significantly different in patients compared with controls. Indicated by increased levels of IL-6 in TLE, epilepsy type is important in determining chronic overproduction of cytokines in refractory focal epilepsy. The results may reflect a chronic immunological process in the brain in patients with refractory epilepsy.

引用

页码：796 / 802

页数：6

共 238 条

[1]

Penkowa M(2001)Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures Neuroscience 102 805-818

[2]

Molinero A(2004)Intranasal administration of human IL-6 increases the severity of chemically induced seizures in rats Neurosci Lett 22 106-110

[3]

Carrasco J(2000)Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus Eur J Neurosc 12 2623-2633

[4]

Hidalgo J(2000)Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice Proc Natl Acad Sci USA 10 11534-11539

[5]

Kalueff AV(2007)Cytokines and acute neurodegeneration Nat Rev Neurosci 2 734-744

[6]

Lehtimaki KA(2002)Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis Epilepsia 43 30-35

[7]

Ylinen A(2005)Brain inflammation of epilepsy: experimental and clinical evidence Epilepsia 46 1724-1743

[8]

Honkaniemi J(1998)Elevated levels of interleukin-6 may occur in cerebrospinal fluid from patients with recent epileptic seizures Epilepsy Res 31 129-133

[9]

Peltola J(2000)Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures Epilepsy Res 41 205-211

[10]

De Simoni MG(1999)Brain-IL-1beta induces local inflammation but systemic anti-inflammatory response through stimulation of both hypothalamic–pituitary-adrenal axis and sympathetic nervous system Brain Res 23 563-571

← 1 2 3 4 5 6 7 8 9 10 →